Celltrion withdraws bid to acquire Baxter

Celltrion withdraws bid to acquire Baxter: COMPANY / Reporter Kim Jisun / 2023-05-09 18:53:02

This article is translated by AI company Flitto and Alhpa Biz neural machine translation technology

(사진=셀트리온제약)

[Alpha Biz=(Chicago) Reporter Kim Jisun] Global Private Equity Fund (PEF) has acquired Baxter International's Biopharma Solution (BPS) division. Celltrion, which pursued the acquisition of the BPS division, is expected to turn to other sales.

According to the pharmaceutical bio industry on the 9th, Baxter International signed a final deal to sell its BPS unit to global PEF, including Advent International and Warburg Pincus, for $4.25 billion (about 5.6168 trillion won) on the 8th (local time).

Founded in 1984, Advent International is a global PEF with extensive investment experience in the medical field. Warburg Pincus is also a global PEF that manages assets worth more than $80 billion and has invested more than $16 billion in more than 180 medical companies since its establishment.

Celltrion, on the other hand, pulled out of the BPS business acquisition race. Celltrion said, "We considered acquiring Baxter International's BPS division, but decided not to pursue it." Previously, the company participated in the acquisition of the BPS division in March to secure stable global production facilities.